(Total Views: 716)
Posted On: 10/26/2020 9:35:53 AM
Post# of 154678
Quote:
but I don't want to hear about anything that is so speculative, so far off, and so unlikely to ever put money in the bank.
Very little speculation with what is known about CCR5, inflammation and stroke. Unless Cytodyn has a shareholder vote to turn the company into a charity it's highly likely that indication will generate good revenue. How far off depends on if we can get to revenue with COVID before leronlimab becomes irrelevant.
(6)
(1)
